News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,929 Results
Type
Article (40419)
Company Profile (261)
Press Release (671240)
Multimedia
Podcasts (70)
Webinars (17)
Section
Business (204469)
Career Advice (2016)
Deals (35476)
Drug Delivery (99)
Drug Development (81235)
Employer Resources (173)
FDA (16310)
Job Trends (14915)
News (345903)
Policy (32684)
Tag
Academia (2558)
Accelerated approval (15)
Adcomms (24)
Allergies (112)
Alliances (49572)
ALS (132)
Alzheimer's disease (1549)
Antibody-drug conjugate (ADC) (193)
Approvals (16392)
Artificial intelligence (379)
Autoimmune disease (61)
Automation (25)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (145)
Biotechnology (175)
Bladder cancer (118)
Brain cancer (44)
Breast cancer (452)
Cancer (3587)
Cardiovascular disease (293)
Career advice (1693)
Career pathing (33)
CAR-T (218)
CDC (42)
Cell therapy (588)
Cervical cancer (30)
Clinical research (67862)
Collaboration (1256)
Company closure (4)
Compensation (905)
Complete response letters (42)
COVID-19 (2671)
CRISPR (70)
C-suite (536)
Cystic fibrosis (124)
Data (4215)
Decentralized trials (2)
Denatured (22)
Depression (91)
Diabetes (412)
Diagnostics (6527)
Digital health (32)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (175)
Drug pricing (154)
Drug shortages (28)
Duchenne muscular dystrophy (190)
Earnings (88663)
Editorial (45)
Employer branding (21)
Employer resources (150)
Events (115070)
Executive appointments (916)
FDA (18639)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (13)
Funding (1149)
Gene editing (155)
Generative AI (28)
Gene therapy (468)
GLP-1 (855)
Government (4597)
Grass and pollen (5)
Guidances (336)
Healthcare (18854)
HIV (42)
Huntington's disease (34)
IgA nephropathy (51)
Immunology and inflammation (198)
Immuno-oncology (15)
Indications (52)
Infectious disease (2879)
Inflammatory bowel disease (168)
Inflation Reduction Act (12)
Influenza (85)
Intellectual property (179)
Interviews (314)
IPO (16607)
IRA (48)
Job creations (3639)
Job search strategy (1426)
Kidney cancer (13)
Labor market (69)
Layoffs (531)
Leadership (24)
Legal (7937)
Liver cancer (84)
Longevity (11)
Lung cancer (514)
Lymphoma (255)
Machine learning (27)
Management (59)
Manufacturing (563)
MASH (127)
Medical device (13595)
Medtech (13616)
Mergers & acquisitions (19721)
Metabolic disorders (1009)
Multiple sclerosis (130)
NASH (16)
Neurodegenerative disease (192)
Neuropsychiatric disorders (47)
Neuroscience (2477)
NextGen: Class of 2025 (6516)
Non-profit (4493)
Now hiring (56)
Obesity (474)
Opinion (236)
Ovarian cancer (124)
Pain (145)
Pancreatic cancer (161)
Parkinson's disease (224)
Partnered (27)
Patents (391)
Patient recruitment (294)
Peanut (52)
People (58168)
Pharmaceutical (63)
Pharmacy benefit managers (23)
Phase I (21125)
Phase II (29879)
Phase III (22234)
Pipeline (2611)
Policy (242)
Postmarket research (2564)
Preclinical (8996)
Press Release (64)
Prostate cancer (183)
Psychedelics (42)
Radiopharmaceuticals (256)
Rare diseases (575)
Real estate (5935)
Recruiting (68)
Regulatory (23371)
Reports (51)
Research institute (2347)
Resumes & cover letters (351)
Rett syndrome (15)
RNA editing (11)
RSV (61)
Schizophrenia (120)
Series A (187)
Series B (145)
Service/supplier (11)
Sickle cell disease (72)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (34)
Startups (3598)
State (2)
Stomach cancer (14)
Supply chain (92)
Tariffs (79)
The Weekly (46)
Vaccines (885)
Venture capital (62)
Weight loss (307)
Women's health (53)
Worklife (17)
Date
Last 7 days (504)
Last 30 days (2060)
Last 365 days (30394)
2025 (23824)
2024 (35218)
2023 (40077)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46539)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (725)
Alabama (71)
Alaska (7)
Arizona (265)
Arkansas (13)
Asia (38584)
Australia (6303)
California (8980)
Canada (2779)
China (813)
Colorado (379)
Connecticut (385)
Delaware (245)
Europe (83116)
Florida (1345)
Georgia (295)
Hawaii (2)
Idaho (60)
Illinois (701)
India (44)
Indiana (429)
Iowa (17)
Japan (301)
Kansas (117)
Kentucky (33)
Louisiana (16)
Maine (67)
Maryland (1187)
Massachusetts (6584)
Michigan (278)
Minnesota (521)
Mississippi (4)
Missouri (107)
Montana (29)
Nebraska (25)
Nevada (102)
New Hampshire (69)
New Jersey (2469)
New Mexico (28)
New York (2449)
North Carolina (1235)
North Dakota (8)
Northern California (4126)
Ohio (275)
Oklahoma (20)
Oregon (36)
Pennsylvania (1898)
Puerto Rico (18)
Rhode Island (43)
South America (1099)
South Carolina (47)
South Dakota (1)
Southern California (3465)
Tennessee (145)
Texas (1388)
United States (32674)
Utah (268)
Virginia (217)
Washington D.C. (76)
Washington State (753)
West Virginia (4)
Wisconsin (76)
Wyoming (1)
711,929 Results for "ardelyx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025
October 14, 2025
·
1 min read
Press Releases
Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer
October 14, 2025
·
3 min read
Press Releases
Ardelyx to Participate in Upcoming September 2025 Investor Conferences
August 25, 2025
·
1 min read
Press Releases
Ardelyx Announces Changes to the Executive Leadership Team
August 5, 2025
·
3 min read
Press Releases
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update
August 5, 2025
·
13 min read
Press Releases
Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025
July 22, 2025
·
1 min read
Press Releases
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025
May 21, 2025
·
1 min read
Deals
Ardelyx, Inc. Reports Employment Inducement Grants - May 30, 2024
Ardelyx, Inc. today announced that on May 23, 2024, the compensation committee of the company’s board of directors granted 10 new non-executive employees options to purchase an aggregate of 210,000 shares of the company’s common stock.
May 30, 2024
·
1 min read
Genetown
Ardelyx, Inc. Reports Employment Inducement Grants - May 14, 2024
Ardelyx, Inc. announced that on May 6, 2024, the compensation committee of the company’s board of directors granted 26 new non-executive employees options to purchase an aggregate of 511,500 shares of the company’s common stock, and granted 32 new non-executive employees an aggregate of 425,050 Restricted Stock Units.
May 14, 2024
·
1 min read
Press Releases
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer
June 3, 2025
·
3 min read
1 of 71,193
Next
